Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

644.20INR
3:58pm IST
Change (% chg)

Rs-5.65 (-0.87%)
Prev Close
Rs649.85
Open
Rs649.85
Day's High
Rs653.70
Day's Low
Rs640.50
Volume
462,406
Avg. Vol
455,041
52-wk High
Rs898.00
52-wk Low
Rs572.40

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.26
Market Cap(Mil.): Rs1,559,406.00
Shares Outstanding(Mil.): 2,399.27
Dividend: 1.00
Yield (%): 0.15

Financials

  SUN.BO Industry Sector
P/E (TTM): 21.20 29.93 30.76
EPS (TTM): 30.66 -- --
ROI: 23.32 15.46 14.89
ROE: 22.83 16.64 16.30

U.S. states sue Mylan, Teva, others for fixing drug prices

WASHINGTON Two years after high generic drug prices became a public controversy, legal cases are starting to land.

16 Dec 2016

U.S. FDA finds quality control problems at Sun Pharma's Halol plant

MUMBAI The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows.

13 Dec 2016

FDA finds quality control problems at Sun Pharma's Halol plant

MUMBAI The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows.

13 Dec 2016

India's Sun Pharma says U.S. finds more concerns at Halol plant

MUMBAI Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Wednesday the U.S. health regulator has informed the company of more concerns found at its Halol manufacturing plant after a recent inspection.

07 Dec 2016

BRIEF-Sun Pharma Industries launches first branded ophthalmic product Bromsite in USA

* Announcement of launches first branded ophthalmic product Bromsite in USA

28 Nov 2016

MEDIA-Sun Pharma's Mohali unit violated manufacturing norms, finds US FDA - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

25 Nov 2016

BRIEF-Sun Pharma enters into deal to buy 85.1 pct of Russia's JSC Biosintez

* Says company has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company

23 Nov 2016

Sun Pharma expects U.S. drug pricing pressures to continue

MUMBAI Sun Pharmaceutical Industries Ltd does not expect pressure on generic drug prices in the United States to abate anytime soon, its managing director said on Thursday, signalling a challenging year ahead in the company's largest market.

10 Nov 2016

UPDATE 2-Sun Pharma expects U.S. drug pricing pressures to continue

* Says expects pricing pressure in U.S. to continue (Adds comments from conference call)

10 Nov 2016

BRIEF-India's Sun Pharma says unsure if Halol plant will be cleared in next 5 months

* India's Sun Pharma said it was unsure if Halol plant would be cleared in the next five months, as the FDA may take time Further company coverage: (Reporting By Zeba Siddiqui)

10 Nov 2016

Earnings vs. Estimates